23 results
Murmurs Needing Echocardiography Evaluation #Management #EM #IM #Cardiology #Murmur #Benign #Characteristics #Echocardiogram #ALiEM
Evaluation #Management #EM ... #IM #Cardiology ... Echocardiogram #ALiEM
Stroke Rate by CHADS2 Score (Gage et al., JAMA, 2001) https://www.ncbi.nlm.nih.gov/pubmed/?term=11401607 #EBM #EM #IM #Cardiology #CHADS2
Score (Gage et al ... term=11401607 #EBM ... #EM #IM #Cardiology ... Score #StrokeRate #ALiEM
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
#PrimaryCare #EM ... #IM #Differential ... Lightheadedness #Table #NEJM
Cardiac etiologies of syncope (red line above) have the highest associated mortality! #EBM #EM #IM #Cardiology
#EBM #EM #IM #Cardiology ... Cardiac #Mortality #ALiEM
Cancer Risk from CT - The lifetime attributable risk of 1 cancer from CT by age,
Cancer Risk from CT ... 1 cancer from CT ... scanned area is: #EBM ... #EM #Radiology ... Radiation #Cancer #ALiEM
Decompression Sickness - The physical examination revealed diffuse violaceous skin mottling over his trunk and arms
Clinical #Derm #EM ... #Pneumatosis #CT ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Pulmonary Renal Syndrome

Definition: Diffuse alveolar hemorrhage + Glomerulonephritis
Presentation (Pulmonary and renal manifestations can occur weeks apart):
anti-ANCA ab, anti-GBM ... resolution chest CT ... Bronchoscopy with serial BAL
Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis - Kupperman et al. NEJM 2018

https://www.nejm.org/doi/full/10.1056/NEJMoa1716816
Study
- Kupperman et al ... NEJM 2018 https ... TessaRDavis #EBM ... Infusion #Rates #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM